Skip to content

Posts tagged ‘Marketing’

US Supreme Court to decide whether Vermont can control the use of prescribing data by IMS health and Pharma companies

January 17th, 2011

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

Icarus Consultants to attend ISGC Meeting in Houston

January 4th, 2011

Daedalus

Sally Church, PhD will be attending the 6th International Society of Gastroenterological Carcinogenesis (ISGC) meeting in Houston from Thursday 6th to Saturday, 8th January, 2011. Hosted by the MD Anderson Cancer Center, the meeting has an impressive line up of key opinion leaders. Further information can be found on the Pharma Strategy Blog.

New cystic fibrosis drug offers hope

December 30th, 2010

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

Update on circulating tumor cells in colorectal cancer

December 29th, 2010

Daedalus

Published by Sally Church on Pharma Strategy Blog

FDA to review Avid Radipharmaceuticals Imaging Biomarker for Alzheimer's Disease

December 27th, 2010

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

My impressions of ASH

December 22nd, 2010

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

DNMT3A Mutations in Acute Myeloid Leukemia – an update

December 21st, 2010

Daedalus

Published by Sally Church on Pharma Strategy Blog

Pharma Strategy Blog named as blog to watch in 2011

December 21st, 2010

Daedalus

Thanks to Priya Kapor of Ogilvy PR for including Pharma Strategy Blog as one her 11 Pharma Blogs for 2011 that have “not only walked the walk but have helped shaped this space in the past year and most likely will moving into 2011.”

Screen shot 2010 12 21 at 12.51.27 PM Pharma Strategy Blog named as blog to watch in 2011

Targeting BAP1 – a future targeted therapy for Uveal Melanoma?

December 21st, 2010

Daedalus

Published by Pieter Droppert on Biotech Strategy Blog

JNJ files NDA for abiraterone in castration resistant prostate cancer

December 20th, 2010

Daedalus

Published by Sally Church on Pharma Strategy Blog